Joel Schlessinger MD FAAD, FAACS, FAAP

Clinical Trials

• Efficacy, Safety, and Tolerability of Topical Terbinafine in Patients With Mild to Moderate Toenail Fungus of the Big Toenail Start of enrollment: 2006 Dec 01

  Completed

  Phase 3

• Safety and Efficacy Study to Compare Two Rosacea Treatment Regimens Start of enrollment: 2007 Mar 01

  Completed

  Phase 4

• Safety and Efficacy of NT 201 (IncobotulinumtoxinA [Xeomin]) in the Treatment of Glabellar Frown Lines Start of enrollment: 2007 Jun 18

  Completed

  Phase 3

• Phase 2 Study for the Treatment of Superficial Lipomas Start of enrollment: 2007 Nov 01

  Completed

  Phase 2

• IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Glabellar Frown Lines Start of enrollment: 2008 Oct 01

  Completed

  Phase 3

• Deoxycholic Acid Injection Submental Fat (SMF) Magnetic Resonance Imaging (MRI) and Subject-reported Outcome Measures Study Start of enrollment: 2009 Dec 01

  Completed

  Phase 2

• Safety and Efficacy of LEO 80185 Topical Suspension in Adolescent Subjects (Aged 12 to 17) With Scalp Psoriasis

  COMPLETED

  PHASE2

• Safety Study of Two Repeat Doses of RT001 for the Treatment of Moderate to Severe Lateral Canthal Lines in Adults Start of enrollment: 2010 May 01

  Completed

  Phase 2

• Study of CD07805/47 Topical Gel in Subjects With Facial Erythema Associated With Rosacea Start of enrollment: 2011 Mar 01

  Completed

  Phase 3

• A Study to Assess Injection Comfort of Two Formulations of ATX-101

  Completed

  Phase 1

• Safety and Efficacy of Econazole Nitrate Foam 1% and Foam Vehicle in Subjects With Tinea Pedis Start of enrollment: 2011 Jun 01

  Completed

  Phase 3

• An International, Multi-centre, Prospective, Non-controlled, Open, Single-group, 8-week Trial in Adolescent Subjects

  COMPLETED

  PHASE2

• Ultherapy® for the Treatment of Erythematotelangiectatic Rosacea Start of enrollment: 2014 May 01

  Completed

  Not Applicable

• Mirvaso in Use Study Start of enrollment: 2014 Sep 01

  Completed

  Phase 4

• Safety Study of DWP-450 (Botulinum Toxin, Type a) to Treat Glabellar Lines - EV-006 Start of enrollment: 2015 May 01

  Completed

  Phase 2

• Study to Evaluate the Safety and Efficacy of LIPO-202 for the Reduction of Submental Subcutaneous Fat Start of enrollment: 2016 Dec 22

  Completed

  Phase 2

• A Study of Baricitinib (LY3009104) in Adult Participants With Moderate to Severe Atopic Dermatitis Start of enrollment: 2018 Feb 20

  Completed

  Phase 3

• Safety, Immunogenicity and Efficacy of GSK S. Aureus Candidate Vaccine (GSK3878858A) When Administered to Healthy Adults (Dose-escalation) and to Adults 18 to 64 Years of Age With a Recent S. Aureus Skin and Soft Tissue Infection (SSTI) Start of enrollment: 2020 Jun 29

  COMPLETED

  PHASE2

• NFX-179 Topical Gel Treatment for Adults With Neurofibromatosis 1 (NF1) and Cutaneous Neurofibromas (cNF) Start of enrollment: 2021 Sep 20

  Completed

  Phase 2

• A Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 60 Weeks of Treatment With a Withdrawal and Retreatment Period Start of enrollment: 2023 Nov 06

  ACTIVE_NOT_RECRUITING

  PHASE3

  Roles: Principal Investigator

• A Study of Eltrekibart (LY3041658) in Adult Participants With Moderate to Severe Hidradenitis Suppurativa Start of enrollment: 2023 Oct 23

  RECRUITING

  PHASE2

• A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata Start of enrollment: 2023 Feb 27

  RECRUITING

  PHASE3

• Join now to see all